Seòmar agus comataidhean

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)
Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Criathragan Hide all filters

Displaying 516 questions Show Answers

Order by |

Question reference: S6W-04338

Asked by: Willie Coffey, MSP for Kilmarnock and Irvine Valley, Scottish National Party
Date lodged: Monday, 15 November 2021
Current Status: Answered by Humza Yousaf on 30 November 2021

To ask the Scottish Government whether it has plans to include COVID-19 booster status on a person's vaccination record.

Question reference: S6W-04291

Asked by: Willie Coffey, MSP for Kilmarnock and Irvine Valley, Scottish National Party
Date lodged: Friday, 12 November 2021
Current Status: Answered by Humza Yousaf on 24 November 2021

To ask the Scottish Government, further to the answer to question S6W-03587 by Humza Yousaf on 8 November 2021, whether hyperbaric treatment is currently being considered by the Scottish Intercollegiate Guidelines Network (SIGN) as a possible treatment, and when a decision will be taken on whether it will be made available to patients.

The UK wide clinical guideline on managing the long-term effects of COVID-19 has been developed collaboratively by the Scottish Intercollegiate Guidelines Network (SIGN), the National Institute for Health and Care Excellence (NICE) and the Royal College of General Practitioners (RCGP).

The evidence reviews on interventions for long COVID were carried out by NICE. At present there is no evidence on hyperbaric oxygen therapy within the guideline.

NICE’s surveillance methods have indicated there is no new evidence which meets the research protocol for interventions on long COVID. However NICE will continue to carry out surveillance on all guideline questions, including the question on interventions, and the results of this surveillance will inform future updates to the living guideline.

There have been long COVID research calls by the National Institute for Health Research and UK Research and Innovation asking for projects investigating possible therapies for long COVID and a number of studies of this type have been funded.

Hyperbaric oxygen therapy treatment has not formed part of any application to either of these calls. Other ongoing calls are open and available for long COVID research applications and if a project on hyperbaric oxygen therapy treatment for long COVID was received, it would be considered.

Question reference: S6O-00421

Asked by: Willie Coffey, MSP for Kilmarnock and Irvine Valley, Scottish National Party
Date lodged: Thursday, 11 November 2021
Current Status: Taken in the Chamber on 18 November 2021

To ask the Scottish Parliamentary Corporate Body what consideration has been given to providing parliamentary services outwith usual hours.

Question reference: S6W-03587

Asked by: Willie Coffey, MSP for Kilmarnock and Irvine Valley, Scottish National Party
Date lodged: Friday, 08 October 2021
Current Status: Answered by Humza Yousaf on 8 November 2021

To ask the Scottish Government, in light of some reported evidence of the beneficial effects of hyperbaric treatments, whether it will consider offering these treatments to people diagnosed with long COVID.

We continue to closely monitor all emerging evidence on new treatments related to the long-term effects of COVID-19 (long Covid) and their clinical effectiveness.

The current Scottish Intercollegiate Guidelines Network (SIGN) clinical guideline , developed in collaboration with the National Institute for Health and Care Excellence (NICE) and the Royal College of General Practitioners (RCGP), provides evidence based information for clinicians on the identification and management of people affected by long-term effects of COVID-19.

The clinical guideline which is being actively reviewed and updated in line with the evidence base on the treatment of long COVID as it continues to develop.

Question reference: S6O-00351

Asked by: Willie Coffey, MSP for Kilmarnock and Irvine Valley, Scottish National Party
Date lodged: Wednesday, 03 November 2021
Current Status: Taken in the Chamber on 10 November 2021

To ask the Scottish Government how the enterprise agencies support economic growth in Ayrshire.

Question reference: S6O-00329

Asked by: Willie Coffey, MSP for Kilmarnock and Irvine Valley, Scottish National Party
Date lodged: Wednesday, 27 October 2021
Current Status: Taken in the Chamber on 4 November 2021

To ask the Scottish Government how it supports the climate tech industry.

Question reference: S6O-00288

Asked by: Willie Coffey, MSP for Kilmarnock and Irvine Valley, Scottish National Party
Date lodged: Wednesday, 20 October 2021
Current Status: Taken in the Chamber on 28 October 2021

To ask the Scottish Government how it can support Scottish food and drink producers, in light of reports of empty supermarket shelves.

Question reference: S6O-00249

Asked by: Willie Coffey, MSP for Kilmarnock and Irvine Valley, Scottish National Party
Date lodged: Wednesday, 29 September 2021
Current Status: Taken in the Chamber on 6 October 2021

To ask the Scottish Government whether it will provide an update on its discussions with the UK Government regarding the digital economy and digital single market.

Question reference: S6O-00215

Asked by: Willie Coffey, MSP for Kilmarnock and Irvine Valley, Scottish National Party
Date lodged: Wednesday, 22 September 2021
Current Status: Taken in the Chamber on 29 September 2021

To ask the Scottish Government what assessment it has made of the impact that the £20 reduction to universal credit could have on households in Kilmarnock and Irvine Valley.

Question reference: S6O-00097

Asked by: Willie Coffey, MSP for Kilmarnock and Irvine Valley, Scottish National Party
Date lodged: Wednesday, 25 August 2021
Current Status: Answered by Maree Todd on 2 September 2021

To ask the Scottish Government whether it will consider establishing a compensation scheme for individuals who have been harmed by sodium valproate.

I have enormous sympathy for everyone who has been harmed by sodium valproate and am committed to making sure the experiences suffered are much less likely to happen again. It is for the UK Government to consider redress through a compensation scheme. This is because the regulation, licensing and safety of medicines is currently reserved to the UK Government. I note that they have elected not to implement this. I will continue to exert positive influence over the UK Government on responding to establishing a compensation scheme for individuals who have been harmed by sodium valproate.